← FDA Drug Approvals (Drugs@FDA)

IRINOTECAN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2008-02-27

Drug application

FDA Application #
ANDA077776
Application type
Abbreviated New Drug Application (Generic)
Brand name
IRINOTECAN HYDROCHLORIDE
Generic name
IRINOTECAN HYDROCHLORIDE
Active ingredients
IRINOTECAN HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
FRESENIUS KABI USA
Manufacturer
Fresenius Kabi USA, LLC
First approval
2008-02-27

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown